Tests higher vitamin D doses for bone strength in children with cystic fibrosis
Compares 6000 and 1000 IU vitamin D daily in children with cystic fibrosis.
Key facts
- Who runs it
- Fakultni Nemocnice V Motole
- Where
- Prague, CzechiaSee the site
- Registry title
- The randomized, double blind study phase III.b of the Comprehensive assessment of the musculoskeletal health in children with cystic fibrosis – on the search for means of improvement
- Status
- Recruiting
- Phase
- Phase 3
- People taking part
- 64 people, planned
- Started
- 2 Oct 2024
- Expected to end
- 1 Jan 2027
- Type of study
- Interventional
- Record updated
- 2 October 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children with cystic fibrosis. It compares two daily doses of vitamin D (cholecalciferol) over two years to see the effect on bones and muscle strength.
- Age
- 6 to 16 years (included)
- Sex
- Boys and girls can both join.
- Disease stage
- A diagnosis of cystic fibrosis is needed. No stage or severity is stated.
- Earlier treatment
- Children cannot join if they had bisphosphonate treatment in the last 18 months.
Main reasons for not taking part
- Lung transplantation, done or planned
- Bisphosphonate treatment in the last 18 months
- Another disease besides cystic fibrosis that is known to affect bone metabolism
- Hypercalcaemia
- Pregnancy
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Diagnosis of cystic fibrosis
- Age from 6 to 16 (included) years
- Willingness of the parent or legal representative to sign the informed consent and allow the child participate in the study
- Woman of childbearing potential need to comply with adequate contraception methods per CTFG guideline
Who cannot take part
- Lung transplantation (done or planned)
- Disease other than CF with known impact on bone metabolism (based on consultancy with main investigator)
- Hypersensitivity to the IMP or additive substance (as per SmPC)
- Contraindication done by SmPC of Vigantol
- Bisphosphonate treatment in the last 18 months
- Hypercalcaemia
- Renal osteodystrophy with hyperphosphatemia
- Pregnancy
Where in Czechia
- Fakultni nemocnice v MotolePrague, CzechiaTaking people
About the trial
What the trial wants to find out
The goal of this study is to assess whether 6000 IU of cholecalciferol per day given over two years to children with cystic fibrosis is superior to 1000 IU of cholecalciferol in normalizing their bone metabolism parameters and in improving their bone density and skeletal muscle force.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Official title
- The randomized, double blind study phase III.b of the Comprehensive assessment of the musculoskeletal health in children with cystic fibrosis – on the search for means of improvement
- Plain-language title
- Tests higher vitamin D doses for bone strength in children with cystic fibrosisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 2 October 2024